Dichloromethane → HCID 66932587, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:29])/[CH:4]=[CH:5]/[C:6]1[CH:7]=[C:8]2[C:25](=[CH:26][CH:27]=1)[O:24][C:11]1([CH2:16][CH2:15][N:14]([C:17](OC(C)(C)C)=O)[CH2:13][CH2:12]1)[CH2:10][C:9]2=[O:28].BrC([C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)C.[CH2:39](Cl)Cl>>[CH3:1][O:2][C:3](=[O:29])/[CH:4]=[CH:5]/[C:6]1[CH:7]=[C:8]2[C:25](=[CH:26][CH:27]=1)[O:24][C:11]1([CH2:16][CH2:15][N:14]([CH:17]([C:33]3[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=3)[CH3:39])[CH2:13][CH2:12]1)[CH2:10][C:9]2=[O:28]Participants
4
Procedure
A mixture of (E)-3-{4-oxo-spiro[chromane-2,4′-piperidine]-6-yl}-acrylic acid methyl ester hydrochloride (500 mg, 1.48 mmol, Intermediate 1), TEA (0.41 ml, 2.96 mmol) and (±)-(1-bromoethyl)benzene (547 mg, 2.96 mmol) in DCM (25 ml) was stirred for 48 h at RT and then washed with brine. The organic phase was dried over Na2SO4 and evaporated. The crude residue was purified by column chromatography (eluent: from DCM to DCM/MeOH 96:4) to give (±)-(E)-3-{1′-(1-phenyl-ethyl)-4-oxo-spiro[chromane-2,4′-piperidine]-6-yl}-acrylic acid methyl ester (546 mg, 90%).
Workup
- washwashed with brine
- dry with materialThe organic phase was dried over Na2SO4
- customevaporated
- customThe crude residue was purified by column chromatography (eluent: from DCM to DCM/MeOH 96:4)
Sources & evidence
- ORD record
- ord-74c7e46473454677967229a11c04dc1b
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115148B2
Reaction notes
Loading…